Retatrutide represents the next generation of weight loss medications, developed by Eli Lilly as a once-weekly injectable peptide that targets three distinct metabolic pathways simultaneously
Its crucial to view weight management as a lifelong journey, emphasizing consistency, flexibility, and a positive mindset to sustain long-term success and promote wellness
These actions lower blood glucose levels, which contributes to weight loss and improved blood sugar control
According to MedPage Today, 10-15% of patients do not respond adequately to semaglutide, though for many others, the issue isn't non-response but diminished response over time
Both Noom and Weight Watchers offer tools for weight management, but they differ in how comprehensively those tools are combined and how medication fits into the overall strategy